Welcome to This Is MS!

     Modules
· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

     Google
Google
Web
This is MS
These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

     Languages
Select Interface Language:


     Who's Online
There are currently, 65 guest(s) and 14 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

     Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.


     Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!


 Doubt Cast on 4th PML Case

Tysabri (Antegren or Natalizumab)As we had suspected, the so-called "4th case" of PML has turned out to be much ado about nothing. According to a New York Times article published today, the 4th patient was "out shopping" when she heard news from the Boston Globe that she had PML (and had consequently died!).
 
"A Biogen Idec official has sent an e-mail message to neurologists suggesting that a suspected fourth case of a brain infection in a patient taking the drug Tysabri was a false alarm, according to two doctors who received the message. The e-mail message said the patient was shopping when she heard news reports last week that she had the potentially fatal infection. 

"Dr. Michael A. Panzara, a medical official at Biogen, sent an e-mail message to some neurologists casting doubts on the [4th PML case] report. Dr. Norman Kachuck of the University of Southern California, one of those who received the e-mail message, said it quoted from a message sent by the doctor treating that fourth suspected patient.

"I just spoke to my patient's daughter, 11:50 a.m., and she is alive and out shopping," the treating doctor wrote, according to Dr. Kachuck. Dr. Kachuck said he thought the patient had had another type of inflammation."

As such, the number of PML cases remains at 3.

Click 'read more' for the link to the NYT article.

Advertisement

Link to Original Article





 
     Login
Nickname

Password

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

     Related Links
· More about Tysabri (Antegren or Natalizumab)
· News by Administrator


Most read story about Tysabri (Antegren or Natalizumab):
Revealing Medical History of 3rd Tysabri Patient with PML


     Article Rating
Average Score: 0
Votes: 0

Please take a second and vote for this article:

Excellent
Very Good
Good
Regular
Bad


     Options

 Printer Friendly Printer Friendly






We encourage you to also visit our Multiple Sclerosis story and support community on Experience Project. Experience Project is a vast and powerful community where people connect anonymously through life experiences. It's made by the same people who built This is MS, on the premise that no one life experience-- like having MS-- defines a person. It now covers over 2 million life stories. Find and share yours!

Experience Project: I have Multiple Sclerosis


Anonymous Confessions | Free Dream Interpretations | Ask Any Question
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.


All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002-8 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.06 Seconds